Lord, Abbett & Co
ACHC icon

Lord, Abbett & Co’s Acadia Healthcare ACHC Stock Holding History

Lord, Abbett & Co’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-369,562
Closed -$15.1M – 817
2018
Q2 		$15.1M Buy
+369,562
New +$14.9M 0.04% 531
2016
Q4 		– Sell
-58,809
Closed -$2.91M – 861
2016
Q3 		$2.91M Sell
58,809
-866
-1% -$45.1K 0.01% 808
2016
Q2 		$3.31M Sell
59,675
-28,103
-32% -$1.64M 0.01% 783
2016
Q1 		$4.84M Sell
87,778
-157,386
-64% -$8.98M 0.02% 708
2015
Q4 		$15.3M Sell
245,164
-130,381
-35% -$8.49M 0.05% 500
2015
Q3 		$24.9M Buy
375,545
+18,205
+5% +$1.4M 0.08% 367
2015
Q2 		$28M Buy
357,340
+41,448
+13% +$2.98M 0.07% 384
2015
Q1 		$22.6M Buy
315,892
+14,887
+5% +$955K 0.06% 454
2014
Q4 		$18.4M Buy
301,005
+237,139
+371% +$13.8M 0.05% 490
2014
Q3 		$3.1M Sell
63,866
-11,994
-16% -$586K 0.01% 824
2014
Q2 		$3.45M Buy
+75,860
New +$3.33M 0.01% 863

Other funds holding ACHC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co's ACHC Position: Q3 2018 in Review

Lord, Abbett & Co sold out of Acadia Healthcare (ACHC) in Q3 2018, closing a stake of 369,562 shares — an estimated $15.1M sold.

Lord, Abbett & Co first reported a position in ACHC in Q2 2014 and held it in 11 quarters. The position peaked at $28M in Q2 2015. 253 funds tracked by Wall St. Rank hold ACHC as of Q3 2018.

  • Lord, Abbett & Co reported no remaining Acadia Healthcare position as of Q3 2018 after selling out during the quarter.
  • Lord, Abbett & Co sold 369,562 Acadia Healthcare shares in Q3 2018, an estimated $15.1M.
  • Lord, Abbett & Co first reported a position in Acadia Healthcare in Q2 2014 and held it in 11 quarters.
  • Lord, Abbett & Co's Acadia Healthcare position peaked at $28M in Q2 2015.
  • 253 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2018.

Based on Lord, Abbett & Co's 13F filing for Q3 2018, filed 14 Nov 2018.